Hahnewald, R., Wegner, W., & Reiss, J. (2009). AAV-mediated gene therapy for metabolic diseases: Dosage and reapplication studies in the molybdenum cofactor deficiency model. BioMed Central.
Citación estilo ChicagoHahnewald, Rita, Waja Wegner, y Jochen Reiss. AAV-mediated Gene Therapy for Metabolic Diseases: Dosage and Reapplication Studies in the Molybdenum Cofactor Deficiency Model. BioMed Central, 2009.
Cita MLAHahnewald, Rita, Waja Wegner, y Jochen Reiss. AAV-mediated Gene Therapy for Metabolic Diseases: Dosage and Reapplication Studies in the Molybdenum Cofactor Deficiency Model. BioMed Central, 2009.
Precaución: Estas citas no son 100% exactas.